
XtalPi
North America, Massachusetts, United States, Cambridge
Description
XtalPi is a pharmaceutical technology company that is reinventing drug discovery by enabling dry lab predictions with wet lab validation.
Investor Profile
XtalPi has backed more than 15 startups, with 9 new investments in the last 12 months alone. The firm has led 6 rounds, about 40% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series Unknown rounds (top funding stages).
- Majority of deals are located in China, United States, Switzerland.
- Strong thematic focus on Biotechnology, Pharmaceutical, Medical.
- Led 6 rounds in the past year.
Stage Focus
- Seed (40%)
- Series A (27%)
- Series Unknown (13%)
- Series B (7%)
- Angel (7%)
- Corporate Round (7%)
Country Focus
- China (47%)
- United States (20%)
- Switzerland (13%)
- United Kingdom (7%)
- Japan (7%)
Industry Focus
- Biotechnology
- Pharmaceutical
- Medical
- Biopharma
- Health Care
- Artificial Intelligence (Ai)
- Therapeutics
- Medical Device
- Alternative Medicine
- Genetics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.